FRANCINE DYGULSKI: Open Payments
NPI 1831501618 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 12 payments from 4 companies in 2025. Trend: 2023 $856 · 2024 $391 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $412 |
| ABBVIE INC. | 5 | $144 |
| Alkermes, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, LYBALVI, FANAPT.
Industry payments across NJ — which companies pay providers there.
